As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama sheds light on the pharmaceuticals industry behind them ...

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

A population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

A new study finds that craving sugar is driven by a deficiency in a gut microbe that releases a substance that acts much like ...

This study links Ffar4, gut microbiota, and sugar preference, highlighting potential strategies for managing diabetes and ...

Many of us feel drowsy during the day, but what causes it, and what can we do about it when it becomes a problem? Sleep ...

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage to avoid the ...

In this era of fitness trackers, we have easy access to our heart rate at any given moment. Every so often, a number catches your eye as it flashes on your Garmin or Apple Watch while you're sitting ...

A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...